OMNI 360 Wealth Inc. Has $419,000 Stock Position in CME Group Inc. $CME

OMNI 360 Wealth Inc. increased its position in shares of CME Group Inc. (NASDAQ:CME) by 10.0% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,520 shares of the financial services provider’s stock after purchasing an additional 138 shares during the quarter. OMNI 360 Wealth Inc.’s holdings in CME Group were worth $419,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in CME. Wayfinding Financial LLC acquired a new stake in shares of CME Group during the 1st quarter worth about $25,000. Cornerstone Planning Group LLC increased its position in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 55 shares in the last quarter. Golden State Wealth Management LLC increased its position in shares of CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Ransom Advisory Ltd acquired a new stake in shares of CME Group during the 1st quarter worth about $31,000. Finally, Alpine Bank Wealth Management acquired a new stake in shares of CME Group during the 1st quarter worth about $32,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity at CME Group

In related news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider owned 17,440 shares of the company’s stock, valued at $4,734,436.80. This trade represents a 40.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William R. Shepard acquired 256 shares of CME Group stock in a transaction that occurred on Wednesday, June 25th. The shares were purchased at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the purchase, the director directly owned 258,196 shares in the company, valued at $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Erste Group Bank cut shares of CME Group from a “strong-buy” rating to a “hold” rating in a research report on Saturday, May 24th. Barclays set a $298.00 price objective on shares of CME Group and gave the company an “equal weight” rating in a research report on Thursday, July 24th. UBS Group lowered their price objective on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a research report on Monday, September 8th. Oppenheimer raised their price objective on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research report on Thursday, July 24th. Finally, Wall Street Zen cut shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Four analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus target price of $260.60.

CME Group Stock Down 0.0%

Shares of NASDAQ CME opened at $262.30 on Friday. The firm has a market capitalization of $94.53 billion, a PE ratio of 25.39, a price-to-earnings-growth ratio of 4.75 and a beta of 0.43. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 1 year low of $212.38 and a 1 year high of $290.79. The firm’s 50-day moving average is $273.60 and its 200-day moving average is $270.45.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the firm earned $2.56 EPS. Equities analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is 48.40%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.